Țară: Regatul Unit
Limbă: engleză
Sursă: MHRA (Medicines & Healthcare Products Regulatory Agency)
Dalteparin sodium
Pfizer Ltd
B01AB04
Dalteparin sodium
25000unit/1ml
Solution for injection
Subcutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 02080100; GTIN: 5012882008178
PACKAGE LEAFLET: INFORMATION FOR THE USER FRAGMIN® 10,000 IU/0.4 ml, 12,500 IU/0.5 ml, 15,000 IU/0.6 ml & 18,000 IU/0.72 ml Solution for Injection dalteparin sodium READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • This medicine has been prescribed for you only. If your doctor has given you this medicine to use at home do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects talk to your doctor, pharmacist or nurse. This includes possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Fragmin is and what it is used for 2. What you need to know before you are given or use Fragmin 3. How Fragmin is given to you 4. Possible side effects 5. How to store Fragmin 6. Contents of the pack and other information 1. WHAT FRAGMIN IS AND WHAT IT IS USED FOR Fragmin is a solution for injection. Its active ingredient is dalteparin sodium. Fragmin belongs to a group of medicines called low molecular weight heparins or antithrombotics, which help prevent the formation of blood clots by thinning the blood. • Fragmin is used to treat blood clots (venous thromboembolism) and to prevent their recurrence. • Venous thromboembolism is a condition where blood clots develop in the legs (deep vein thrombosis) or the lungs (pulmonary embolism), e.g. after surgery, prolonged bed-rest or in patients with certain types of cancer. Ask your doctor if you are unsure why you have been given Fragmin. Page 1 of 9 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN OR USE FRAGMIN YOU SHOULD NOT BE GIVEN OR USE FRAGMIN: • if you are allergic (hypersensitive) to the active ingredient dalteparin sodium or a similar product or any of the other ingredients of this medicine (listed in section 6). • if you have an active stomach ulcer Citiți documentul complet
OBJECT 1 FRAGMIN 18,000 IU/0.72ML SOLUTION FOR INJECTION Summary of Product Characteristics Updated 19-May-2016 | Pfizer Limited 1. Name of the medicinal product Fragmin ® 18,000 IU/0.72ml solution for injection 2. Qualitative and quantitative composition Fragmin 18,000 IU: single dose syringe containing dalteparin sodium 18,000 IU (anti-Factor Xa) in 0.72 ml solution for injection equivalent to 25,000 IU/ml. For excipients see section 6.1 Fragmin does not contain preservatives. *Potency is described in International anti-Factor Xa units (IU) of the 1st International Standard for Low Molecular Weight Heparin. 3. Pharmaceutical form Solution for injection 4. Clinical particulars 4.1 Therapeutic indications Treatment of venous thromboembolism (VTE) presenting clinically as deep vein thrombosis (DVT), pulmonary embolism (PE) or both. Patients with solid tumours: Extended treatment of symptomatic venous thromboembolism (VTE) and prevention of its recurrence. 4.2 Posology and method of administration TREATMENT OF VENOUS THROMBOEMBOLISM (VTE) PRESENTING CLINICALLY AS DEEP VEIN THROMBOSIS (DVT), PULMONARY EMBOLISM (PE) OR BOTH. ADULTS A single dose of Fragmin is administered subcutaneously, once daily according to the following weight ranges. Monitoring of the anticoagulant effect is not usually necessary. WEIGHT (KG) DOSE (IU) 46-56 10,000 IU 57-68 12,500 IU 69-82 15,000 IU 83 AND OVER 18,000 IU The single daily dose should not exceed 18 000 IU. Simultaneous anti-coagulation with vitamin K antagonists can be started immediately. Treatment with Fragmin is continued until the prothrombin complex levels (Factor II, VII, IX and X) have decreased to a therapeutic level. At least five days of combined treatment is normally required. For patients with an increased risk of bleeding, it is recommended that Fragmin be administered according to the twice daily regimen detailed in the Summary of Product Characteristics for Fragmin 10,000 IU/1ml ampoules or Fragmin Multidose Vial. PAEDIATRIC POPULATION The safety and efficacy of d Citiți documentul complet